SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,859.84 -375.62
( -0.49%)

Global Indices

Nasdaq

53,360.44 -120.34
(-0.23%)

Dow Jones

7,713.14 -52.92
(-0.68%)

Hang Seng

65,335.94 -2,124.79
(-3.15%)

Nikkei 225

10,735.70 15.40
(0.14%)

Forex

USD-INR

95.60 0.07
(0.07%)

EUR-INR

110.76 0.24
(0.21%)

GBP-INR

129.56 0.29
(0.22%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.9559391

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

148.49

98533.48

EPS(TTM)

Face Value()

Div & Yield %

7.95

0.68

Back

abans enterprises ltd

Bazel International consolidated net profit rises 75.00% in the December 2025 quarter

Feb 13,2026

Net profit of Bazel International rose 75.00% to Rs 0.21 crore in the quarter ended December 2025 as against Rs 0.12 crore during the previous quarter ended December 2024. Sales rose 59.21% to Rs 1.21 crore in the quarter ended December 2025 as against Rs 0.76 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1.21	0.76	59
OPM %	24.79	44.74	-
PBDT	0.15	0.13	15
PBT	0.15	0.10	50
NP	0.21	0.12	75

76,859.84 -375.62 ( -0.49%)

53,360.44 -120.34 (-0.23%)

7,713.14 -52.92 (-0.68%)

65,335.94 -2,124.79 (-3.15%)

10,735.70 15.40 (0.14%)

95.60 0.07 (0.07%)

110.76 0.24 (0.21%)

129.56 0.29 (0.22%)

0.60 0.00 (0.12%)